Local drug delivery to the inner ear using biodegradable materials

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Kral A, O’Donoghue GM. Profound deafness in childhood. N. Engl. J. Med.363(15),1438–1450 (2010).
  Medline CASGoogle Scholar
• 2  Sprinzl GM, Riechelmann H. Current trends in treating hearing loss in elderly people: a review of the technology and treatment options – a mini-review. Gerontology56(3),351–358 (2010).
  Google Scholar
• 3  Liberman MC, Rosowski JJ, Lewis RF. Cochlear function and dysfunction. In: Schuknecht’s Pathology of the Ear (Third Edition). Merchant SN, Nadol JB (Eds). People’s Medical Publishing House, CT, USA 104–127 (2010).
  Google Scholar
• 4  Merchant SN. Degeneration of auditory and vestibular end organs. In: Schuknecht’s Pathology of the Ear (Third Edition). Merchant SN, Nadol JB (Eds). People’s Medical Publishing House, CT, USA, 631–663 (2010).
  Google Scholar
• 5  Diaz RC. Inner ear protection and regeneration: a ‘historical’ perspective. Curr. Opin. Otolaryngol. Head Neck Surg.17(5),363–372 (2009).
  MedlineGoogle Scholar
• 6  Schreiber BE, Agrup C, Haskard DO, Luxon LM. Sudden sensorineural hearing loss. Lancet375,1203–1211 (2010).
  MedlineGoogle Scholar
• 7  Oshima K, Suchert S, Blevins NH, Heller S. Curing hearing loss: patient expectations, health care practitioners, and basic science. J. Commun. Disord.43(4),311–318 (2010).
  MedlineGoogle Scholar
• 8  Angelborg C, Hillerdal M, Hultcrantz E et al. The microsphere method for studies of inner ear blood flow. ORL J. Otorhinolaryngol. Relat. Spec.50,355–362 (1998).
  Google Scholar
• 9  Juhn SK, Rybak LP. Labyrinthine barriers and cochlear homeostasis. Acta Otolaryngol.91,529–534 (1981).
  Medline CASGoogle Scholar
• 10  Horie RT, Sakamoto T, Nakagawa T et al. Stealth-nanoparticle strategy for enhancing the efficacy of steroids in mice with noise-induced hearing loss. Nanomedicine5,1331–1340 (2010).▪▪ Demonstrates the importance of drug-delivery systems in systemic treatment for inner ear diseases.
  Medline CASGoogle Scholar
• 11  Salt AN, Hale SA, Plonkte SK. Perilymph sampling from the cochlear apex: a reliable method to obtain higher purity perilymph samples from scala tympani. J. Neurosci. Methods153,121–129 (2006).
  Medline CASGoogle Scholar
• 12  Plontke SK, Salt AN. Simulation of application strategies for local drug delivery to the inner ear. ORL J. Otorhinolaryngol. Relat. Spec.68,386–392 (2006).▪▪ Helpful for understanding why drug-delivery systems are crucial for local drug delivery to the inner ear
  Medline CASGoogle Scholar
• 13  McCall AA, Swan EE, Borenstein JT, Sewell WF, Kujawa SG, McKenna MJ. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear.31(2),156–165 (2010).
  MedlineGoogle Scholar
• 14  Salt AN, Plonkte SK. Principles of local drug delivery to the inner ear. Audiol. Neurotol.14,350–360 (2009).
  Medline CASGoogle Scholar
• 15  Ersner MS. Transtympanic injection of anesthetics for the treatment of Menière’s syndrome. Arch. Otorhinolaryngol.43–52 (1951).
  Google Scholar
• 16  Schuknecht HF. Ablation therapy for the relief of Meniere’s disease. Laryngoscope66,859–870 (1956).
  Medline CASGoogle Scholar
• 17  Hu A, Parnes L. Intratympanic steroids for inner ear disorders, a review. Audiol. Neurootol.14,373–382 (2009).▪ A well-organized review for the efficacy of intratympanic injection of steroids for inner ear diseases.
  Medline CASGoogle Scholar
• 18  Li P, Zeng XL, Ye J et al. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiol. Neurootol.16(3),198–202 (2010).
  MedlineGoogle Scholar
• 19  Kakehata S, Sasaki A, Futai K et al. Daily short-term intratympanic dexamethasone treatment alone as an initial or salvage treatment for idiopathic sudden sensorineural hearing loss. Audiol. Neurootol.16(3),191–197 (2010).
  MedlineGoogle Scholar
• 20  Nomura Y. Otological significance of the round window. Adv. Otorhinolaryngol.33,1–162 (1984).
  Medline CASGoogle Scholar
• 21  Hiraumi H, Nakagawa T, Ito J. Efficiency of a transtympanic approach to the round window membrane using a microendoscope. Eur. Arch. Otorhinolaryngol.266,367–371 (2009)
  MedlineGoogle Scholar
• 22  Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Meniere’s disease. Laryngoscope114,102–105 (2004).
  Medline CASGoogle Scholar
• 23  Thomsen J, Charabi S, Tos M. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Ménière’s disease. Eur. Arch. Otorhinolaryngol.257,362–365 (2000).
  Medline CASGoogle Scholar
• 24  Schoendorf J, Neugebauer P, Michel O. Continuous intratympanic infusion of gentamicin via a microcatheter in Ménière’s disease. Otolaryngol. Head Neck Surg.124,203–207 (2001).
  Medline CASGoogle Scholar
• 25  Shinohara T, Bredberg G, Ulfendahl M et al. Neurotrophic factor intervention restores auditory function in deafened animals. Proc. Natl Acad. Sci. USA99(3),1657–1660 (2002)
  Medline CASGoogle Scholar
• 26  Takemura K, Komeda M, Yagi M et al. Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig. Hear Res.196,58–68 (2004).
  Medline CASGoogle Scholar
• 27  Yamagata T, Miller JM, Ulfendahl M et al. Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs. J. Neurosci. Res.78(1),75–86 (2004).
  Medline CASGoogle Scholar
• 28  Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol.122,698–702 (2002).
  Medline CASGoogle Scholar
• 29  Plontke SK, Lowenheim H, Mertens J et al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope119(2),359–369 (2009).▪ A clinical trial using an implantable minipump for treatment of sensorineural hearing loss.
  Medline CASGoogle Scholar
• 30  Yagi M, Magal E, Sheng Z et al. Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum. Gene Ther.10,813–823 (1999).
  Medline CASGoogle Scholar
• 31  Luebke AE, Foster PK, Muller CD et al. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum. Gene Ther.12,773–781 (2001).
  Medline CASGoogle Scholar
• 32  Hakuba N, Watabe K, Hyodo J et al. Adenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbils. Gene Ther.10,426–433 (2003).
  Medline CASGoogle Scholar
• 33  Ishimoto S, Kawamoto K, Stöver T, Kanzaki S, Yamasoba T, Raphael Y. A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea. Audiol. Neurootol.8(2),70–79 (2003).
  Medline CASGoogle Scholar
• 34  Okano T, Nakagawa T, Kita T, Endo T, Ito J. Cell-gene delivery of brain-derived neurotrophic factor to the mouse inner ear. Mol. Ther.14,866–871 (2006)
  Medline CASGoogle Scholar
• 35  Warnecke A, Wissele K, Hoffman A et al. The biological effects of cell-delivered brain-derived neurotrophic factors on cultured spiral ganglion cells. Neuroreport18,1683–1686 (2007).
  Medline CASGoogle Scholar
• 36  Yoshida A, Kitajiri S, Nakagawa T, Hashido K, Inaoka T, Ito J. Adipose tissue-derived stromal cells protect hair cells from aminoglycoside. Laryngoscope121(6),1281–1286 (2011).
  Medline CASGoogle Scholar
• 37  Salt AN, Plontke S. Local inner ear drug delivery and pharmacokinetics. Drug Discov. Today10,1299–1306 (2005).▪ A well written review of a history of local drug delivery to the inner ear.
  Medline CASGoogle Scholar
• 38  Nakagawa T, Ito J. Local drug delivery to inner ear for treatment of hearing loss. Curr. Drug Ther.3,143–147 (2008).
  CASGoogle Scholar
• 39  Tamura T, Kita T, Nakagawa T et al. Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope115,2000–2005 (2005).▪ A first documentation showing the potential of nanoparticles for the treatment of the inner ear.
  Medline CASGoogle Scholar
• 40  Ge X, Jackson RL, Liu J et al. Distribution of PLGA nanoparticles in chinchilla cochleae. Otolaryngol. Head Neck Surg.137(4),619–623 (2007).
  MedlineGoogle Scholar
• 41  Zou J, Saulnier P, Perrier T et al. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J. Biomed. Mater. Res. B Appl. Biomater.87(1),10–18 (2008).
  MedlineGoogle Scholar
• 42  Scheper V, Wolf M, Scholl M et al. Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Nanomedicine4(6),623–635 (2009).
  Medline CASGoogle Scholar
• 43  Zhang Y, Zhang W, Löebler M et al. Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Int. J. Pharm. (2011) (In press).
  Google Scholar
• 44  Kopke RD, Wassel RA, Mondalek F et al. Magnetic nanoparticles: inner ear targeted molecule delivery and middle ear implant. Audiol. Neurootol.11(2),123–133 (2006).
  MedlineGoogle Scholar
• 45  Zou J, Zhang W, Poe D et al. MRI manifestation of novel superparamagnetic iron oxide nanoparticles in the rat inner ear. Nanomedicine5(5),739–754 (2010).
  Medline CASGoogle Scholar
• 46  Zhang Y, Zhang W, Johnston AH et al. Improving the visualization of fluorescently tagged nanoparticles and fluorophore-labeled molecular probes by treatment with CuSO₄ to quench autofluorescence in the rat inner ear. Hear Res.269(1–2),1–11 (2010).
  Medline CASGoogle Scholar
• 47  Roy S, Johnston AH, Newman TA et al. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery. Int. J. Pharm.390(2),214–224 (2010).▪ Showing the capability of nanoparticles for cell-specific targeting delivery in the inner ear.
  Medline CASGoogle Scholar
• 48  Horie RT, Sakamoto T, Nakagawa T et al. Sustained delivery of lidocaine into the cochlea using PLGA microparticles. Laryngoscope120,377–383 (2010).▪ Use of PLGA microparticles for lidocaine delivery into the inner ear.
  Medline CASGoogle Scholar
• 49  Paulson DP, Abuzeid W, Jiang H, Oe T, O’Malley BW, Li D. A novel controlled local drug delivery system for inner ear disease. Laryngoscope118(4),706–711 (2008).
  Medline CASGoogle Scholar
• 50  Saber A, Strand SP, Ulfendahl M. Use of the biodegradable polymer chitosan as a vehicle for applying drugs to the inner ear. Eur. J. Pharm. Sci.39(1–3),110–115 (2010).
  Medline CASGoogle Scholar
• 51  Saber A, Laurell G, Bramer T et al. Middle ear application of a sodium hyaluronate gel loaded with neomycin in a Guinea pig model. Ear Hear.30(1),81–89 (2009).
  MedlineGoogle Scholar
• 52  Noushi F, Richardson RT, Hardman J, Clark G, O’Leary S. Delivery of neurotrophin-3 to the cochlea using alginate beads. Otol. Neurotol.26,528–533 (2005).
  MedlineGoogle Scholar
• 53  Young S, Wong M, Tabata Y et al. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release109,256–274 (2005).▪ A review article describing characteristics of gelatin polymers as a vehicle of drugs.
  Medline CASGoogle Scholar
• 54  Endo T, Nakagawa T, Kita T et al. A novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope115,2000–2005 (2005).▪▪ A key article showing the capability of gelatin polymers for sustained delivery of a neurotrophin into the inner ear.
  MedlineGoogle Scholar
• 55  Lee KY, Nakagawa T, Okano T et al. Novel therapy for hearing loss: delivery of insulin-like growth factor-1 to the cochlea using gelatin hydrogel. Otol. Neurotol.28,976–981 (2007).
  MedlineGoogle Scholar
• 56  Iwai K, Nakagawa T, Endo T et al. Cochlear protection by local IGF-1 application using biodegradable hydrogel. Laryngoscope116,526–533 (2006).
  Google Scholar
• 57  Fujiwara T, Hato N, Nakagawa T et al. Insulin-like growth factor 1 treatment via hydrogels rescues cochlear hair cells from ischemic injury. Neuroreport19,1585–1588 (2008).
  Medline CASGoogle Scholar
• 58  Inaoka T, Nakagawa T, Kikkawa YS et al. Local application of hepatocyte growth factor using gelatin hydrogels attenuates noise-induced hearing loss in guinea pigs. Acta Otolaryngol.129,453–457 (2009).
  Medline CASGoogle Scholar
• 59  Nakagawa T, Sakamoto T, Hiraumi H et al. Topical insulin-like growth factor-1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial. BMC Med.8,76 (2010).▪ A clinical trial to test the safety and efficacy of local application of IGF1 using gelatin polymers for the treatment of acute sensorineural hearing loss.
  Medline CASGoogle Scholar
• 60  Ruel-Gariepy E, Chenite A, Chaput C, Guirguis S, Leroux J. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int. J. Pharm.203,89–98 (2000).
  Medline CASGoogle Scholar
• 61  Wang X, Dellamary L, Fernandez R et al. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiol. Neurootol.14(6),393–401 (2009).
  Medline CASGoogle Scholar
• 62  Salt AN, Hartsock J, Plontke S, Lebel C, Piu F. Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation. Audiol. Neurootol.16(5),323–335 (2010).
  MedlineGoogle Scholar
• 63  Piu F, Wang X, Fernandez R et al. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol. Neurotol.32(1),171–179 (2011).▪ A sustained delivery system using synthetic materials for steroids into the inner ear.
  MedlineGoogle Scholar
• 64  Chen JP, Leu YL, Fang CL, Chen CH, Fang JY. Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin. J. Pharm. Sci.100(2),655–666 (2011).
  Medline CASGoogle Scholar
• 65  Tateya I, Nakagawa T, Iguchi F et al. Fate of neural stem cells grafted into injured inner ears of mice. Neuroreport14,1677–1681 (2003).
  MedlineGoogle Scholar
• 66  Okano T, Nakagawa T, Endo T et al. Engraftment of embryonic stem cell-derived neurons into the cochlear modiolus. Neuroreport16,1919–1922 (2005).
  MedlineGoogle Scholar
• 67  Corrales CE, Pan L, Li H et al. Engraftment and differentiation of embryonic stem cell-derived neural progenitor cells in the cochlear nerve trunk: growth of processes into the organ of Corti. J. Neurobiol.66,1489–1500 (2006).
  MedlineGoogle Scholar
• 68  Reyes JH, O’Shea KS. Glutamatergic neuronal differentiation of mouse embryonic stem cells after transient expression of neurogenin 1 and treatment with BDNF and GDNF: in vitro and in vivo studies. J. Neurosci.28,12622–12631 (2008).
  Medline CASGoogle Scholar
• 69  Oshima K, Shin K, Diensthuber M et al. Mechanosensitive hair cell-like cells from embryonic and induced pluripotent stem cells. Cell141,704–716 (2010).
  Medline CASGoogle Scholar
• 70  Izumikawa M, Minoda R, Kawamoto K et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat. Med.11,271–276 (2005).
  Medline CASGoogle Scholar
• 71  Staecker H, Praetorius M, Baker K et al. Vestibular hair cell regeneration and restoration of balance function induced by math1 gene transfer. Otol. Neurotol.28,223–231 (2007).
  MedlineGoogle Scholar
• 72  Yamamoto N, Tanigaki K, Tsuji M et al. Inhibition of Notch/RBP-J signaling induces hair cell formation in neonate mouse cochleas. J. Mol. Med.84,37–45 (2006).
  Medline CASGoogle Scholar
• 73  Hori R, Nakagawa T, Sakamoto T et al. Pharmacological inhibition of Notch signaling in the mature guinea pig cochlea. Neuroreport18,1911–1914 (2007).
  Medline CASGoogle Scholar
• 74  Ma EY, Rubel EW, Raible DW. Notch signaling regulates the extent of hair cell regeneration in the zebrafish lateral line. J. Neurosci.28,2261–2273 (2008).
  Medline CASGoogle Scholar
• 75  Daudet N, Gibson R, Shang J et al. Notch regulation of progenitor cell behavior in quiescent and regenerating auditory epithelium of mature birds. Dev. Biol.326,86–100 (2008).
  MedlineGoogle Scholar
• 101  OTO-104 for Ménière’s disease. http://clinicaltrials.gov/ct2/show/NCT01084525
  Google Scholar